Clinical Trials Logo

Intracranial Arterial Diseases clinical trials

View clinical trials related to Intracranial Arterial Diseases.

Filter by:
  • None
  • Page 1

NCT ID: NCT05217459 Completed - Stent Restenosis Clinical Trials

The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease

Start date: July 4, 2022
Phase: N/A
Study type: Interventional

The primary objective of this trial is to evaluate the safety and efficacy of SINOMED IS- DES in patients with symptomatic intracranial atherosclerotic stenosis.

NCT ID: NCT05063630 Recruiting - Ischemic Stroke Clinical Trials

Intracranial Stenting in Non-acute Symptomatic Ischemic Stroke

INSIS
Start date: May 1, 2019
Phase: N/A
Study type: Interventional

In non-acute symptomatic ischemic stroke, the decision-making of medical treatment plus intracranial stenting has been more and more popular, especially in patients with intracranial large severe stenosis or occlusive artery. Nonetheless, there is no evidence from randomized controlled trials evaluating the efficacy of this treatment after the Wingspan Stent System Post Market Surveillance (WEAVE) and Wingspan One Year Vascular Imaging Events and Neurologic Outcomes (WOVEN) trial compared with medical treatment alone. This trial was to investigate whether medical treatment plus intracranial stenting would prevent the recurrent ischemic stroke in the territory of the symptomatic intracranial artery during 1-year follow-up.

NCT ID: NCT04927156 Recruiting - Clinical trials for Acute Ischemic Stroke

Safety, Performance and Usability of BALT Medical Devices: The EVIDENCE Post Marketing Clinical Follow-up Platform

Start date: July 12, 2021
Phase:
Study type: Observational

BALT has designed an electronic platform to continue collecting clinical data as part of the post-marketing clinical follow-up of its devices. This platform is purely exploratory, without hierarchical order of the objectives and associated outcomes.

NCT ID: NCT03916133 Completed - Ischemic Stroke Clinical Trials

Analysis of Selective Cerebrovascular Distribution With FDCT in the Angiosuite

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the clinical feasibility of the angiographic Flat Detector CT perfusion imaging (6s PBV) technique. The investigators will examine the specific vessel distribution of patients with steno-occlusive disease, treated with a surgical extracranial-intracranial bypass and assess the cerebral perfusion during test occlusion upon a neurovascular treatment and in intracranial tumor patients referred for potential pre-operative embolization. This study encompasses three scientific objectives: 1. What is the selective contribution of an individual bypass artery to the brain perfusion? 2. Is a selective intra-arterial angiographic perfusion examination useful in the decision-making of performing pre-operative embolization of intracranial tumors? 3. What is the usefulness of performing additive 6s PBV images compared to classical 2D angiography and/or clinical neurological evaluation in case of test occlusion in the evaluation of possible mother vessel occlusion in treatment of complex neurovascular diseases?

NCT ID: NCT02341794 Recruiting - Clinical trials for Intracranial Arterial Diseases

Rosuvastatin Treatment for Intracranial Arterial Stenosis Based on Magnetic Resonance Angiography

Start date: January 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effects of rosuvastatin treatment on degree of intracranial arterial stenosis.

NCT ID: NCT00703794 Completed - Vascular Diseases Clinical Trials

Researching AXIUM Coiling Experience and Recanalization (RACER)

RACER
Start date: June 2008
Phase:
Study type: Observational [Patient Registry]

The data collected in this study will be used to support International Regulatory submissions. The study objective is to evaluate the continued safety and efficacy of the AXIUM Progressive Coil System. This Device has been used clinically at approximately 150 Institutions under FDA 510(k) clearance since April 24, 2007. The device received CE authorization on June 30, 2007. Through December 2007, more than 1000 patients have been treated with the AXIUM Coils.